Global Haemophilus Parasuis Bivalent Vaccine Market Growth 2025-2031

The global Haemophilus Parasuis Bivalent Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Haemophilus parasuis disease, also known as Grazer"s disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.

United States market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Haemophilus Parasuis Bivalent Vaccine players cover Zoetis, Boehringer-Ingelheim, Eurovet, Hipra, Nisseiken, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Haemophilus Parasuis Bivalent Vaccine Industry Forecast” looks at past sales and reviews total world Haemophilus Parasuis Bivalent Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Haemophilus Parasuis Bivalent Vaccine sales for 2025 through 2031. With Haemophilus Parasuis Bivalent Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Haemophilus Parasuis Bivalent Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Haemophilus Parasuis Bivalent Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Haemophilus Parasuis Bivalent Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Haemophilus Parasuis Bivalent Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Haemophilus Parasuis Bivalent Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Haemophilus Parasuis Bivalent Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Parasuis Bivalent Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Bivalent Inactivated Vaccine
Trivalent Inactivated Vaccine
Quadrivalent Inactivated Vaccine

Segmentation by Application:
Piglets
Adults Pigs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer-Ingelheim
Eurovet
Hipra
Nisseiken
Merck Animal Health
SPAH
Pulike Biological Engineering
China Animal Husbandry Industry
Wuhan Keqian Biology
Wo Hua Biotech
Zhejiang Ceva Ebvac Biotech
Luoyang Huizhong Biotech
Beijing Centrebio Biology
Shandong Huahong Bioengineering
Ringpu

Key Questions Addressed in this Report

What is the 10-year outlook for the global Haemophilus Parasuis Bivalent Vaccine market?

What factors are driving Haemophilus Parasuis Bivalent Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Haemophilus Parasuis Bivalent Vaccine market opportunities vary by end market size?

How does Haemophilus Parasuis Bivalent Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more